CONTRACEPTIVE FAILURE RATES AMONG MEDICAID AND NON-MEDICAID ENROLLEES

Author(s)

W. David Bradford, PhD, Professor1, Jeffrey S McCullough, PhD, Assistant Professor2, Joanne Chang, MD, PhD, Head of US Health Economics, Outcomes & Reimbursement3, Antonio C. Costales, MD, Medical Director3, Joseph A. Gricar, MS, Health Economics Consultant41Medical University of South Carolina, Charleston, SC, USA; 2 University of Minnesota, Minneapolis, MN, USA; 3 Bayer HealthCare Pharmaceuticals, Inc, Wayne, NJ, USA; 4 Independent Health Care Consultant, New York, NY, USA

Objective: Contraceptive efficacy depends both on patient compliance and the characteristics of the method used. Efficacy rates can thus vary across different populations, particularly in women employing user-dependent methods (i.e., oral, condoms). This study measured the contraceptive failure rates in a Medicaid and a non-Medicaid population and evaluated the efficacy variance between the two groups. Methods: Monthly contraceptive-use histories were constructed for all women using data from the 2002 National Survey of Family Growth (NSFG VI). Contraceptive use was defined by first contraception method mentioned in the survey. Poly-modal use was not defined. Women were classified as Medicaid enrollees if they reported having Medicaid coverage in the 12 months prior to the survey, or reported Medicaid payment for services. The final dataset included 1208 Medicaid-enrolled women and 6435 non-Medicaid enrolled women. Pregnancy rates were calculated each month and then annualized for women using user-dependent methods (oral contraceptives [OC], condom) or non-daily methods (IUD, injected, implanted birth control). Results: Average annual contraceptive failure rates for Medicaid vs. non-Medicaid women were: oral pill - 1.15% vs 0.13% (p=0.0051); condom - 2.05% vs. 0.55% (p=0.0015); IUD - 0.52% vs. 0.16% (p=0.5156); injected or implanted - 0.27% vs. 0.13% (p=0.3940). OC failure rate was nearly 9-times higher in the Medicaid population than in the non-Medicaid population. Failures rates for IUD, injectables and implants were also higher but the differences were not statistically significant. Conclusion: Study results largely correspond to previous published estimates (i.e., Trussell, 2004). Contraception failure rates for user-dependent methods were substantially greater in a Medicaid population than those in a non-Medicaid plan. The efficacy rates of non-daily methods were not statistically different across the two populations and thus may be the more appropriate option for a Medicaid patient or other patient subpopulations shown to have compliance issues.

Conference/Value in Health Info

2008-05, ISPOR 2008, Toronto, Ontario, Canada

Value in Health, Vol. 11, No. 3 (May/June 2008)

Code

PIH2

Topic

Clinical Outcomes, Epidemiology & Public Health

Topic Subcategory

Comparative Effectiveness or Efficacy

Disease

Reproductive and Sexual Health

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×